Sungai Penuh, 15 Juli 2024

Nomor :173/Ajwa/Dir-1/VII/2024
Perihal : Vaksinasi Miningitis

Kepada
Yth. Calon jamaah Ajwa Tour Indonesia
di-
Tempat

[Link]

Semoga bapak/ibu senantiasa dalam bimbingan dan lindungan Allah SWT serta mendapatkan
kemudahan dalam menjalankan aktifitas sehari-hari amin.

Maka bersama ini kami sampaikan dan menghimbau kepada bapak/ibu seluruh calon jamaah
ajwa tour Indonesia untuk melakukan Vasinisasi Miningitis mengingat sebagai berikut:

1. Mengingat aturan yang di keluarkan oleh Kerajaaan Arab Saudi menjadi salah satu
syarat untuk masuk ke Kerajaan Arab Saudi bagi orang yang ingin melaksakan
ibadah Umrah.
2. Sehubungan dengan adanya Surat edaran terbaru dari General Authority of civil
Avation (GACA) kingdom of Saudi Arabia
3. Mengingat Hal tersebut kami menyampaikan bahwa vaksin Miningitis bagi
jamaah umrah adalah Wajib

Sehubungan hal tersebut agar seluruh jamaah untuk dapat memenuhi ketentuan yang berlaku
pada saat melaksanakan kegiatan umrah agar segala sesuatunya dapat berjalan dengan baik dan
lancar, terutama bagi kesehatan jamaah.

Demikian pemberitahuan ini kami sampaikan, atas perhatian dan kerjasamanya kami
ucapkan terima kasih.

Wassalamualaikum Wr. Wb.

Hormat kami,
PT. Andalas Jaya Wisata

H. Angga Perdana, [Link]

Direktur Utama
 Health Requirements and Recommendations for Travelers to Saudi
Arabia for Umrah – 1445H (2024)
The Ministry of Health in the Kingdom of Saudi Arabia issues this document to address health requirements and
recommendations for visitors traveling to Saudi Arabia for the purposes of Umrah 1445 (2024).

1 Required vaccinations.
Target
N Vaccine Target Group Approved Vaccine
Countries
 Quadrivalent (ACYW) Polysaccharide Vaccine, 10
days prior to arrival and should not exceed 3 years.
 Quadrivalent (ACYW) Conjugated1 Vaccine within
the last 5 years, and at least 10 days prior to arrival.
Meningococcal All individuals, 1 year old and
 Health authorities at the pilgrims' country of origin
1 All countries should ensure their vaccination within the required
meningitis above, arriving for Umrah.
validity period and make sure that the type of
vaccine and its date is clearly shown in the
vaccination certificate. If the vaccine type is not
indicated on the certificate, it will be considered
valid for 3 years only.
States reporting
cases of WPV1 or At least one dose of bivalent oral polio vaccine
2 Poliomyelitis All travelers
cVDPV1 (Appendix (bOPV) or inactivated polio vaccine (IPV) 2
1-Table 1)
States reporting
cVDPV2 positive
human samples or At least one dose of (IPV)3, if (IPV) is not available,
3 Poliomyelitis All travelers Acute Flaccid vaccination with at least one dose of oral polio
Paralysis (AFP) vaccine (OPV)3 is accepted.
cases (Appendix 1-
Table 2)
Countries or areas
Yellow Fever vaccine.
All travelers above 9 months at risk of yellow
4 Yellow Fever The Yellow Fever vaccination certificate is valid for life
of age fever transmission
starting 10 days after vaccination.
(Appendix 2)

_________ _______ _______ ______ _______ _______ ______ _______ _______ ______ _______ ______ _______ _______ ______ _______ _______ ______ _______ _______ ______ _______ ______ _______ _______ ______ _______ _______ ______

1Current evidence suggests that conjugate vaccines are safe and effective for those above 55 years of age.
2it is recommended to get (bOPV) or (IPV) dose within the previous 12 months and administered not less than 4 weeks prior to arrival.
3 it is recommended to get (OPV) dose within the previous 6 months and administered not less than 4 weeks prior to arrival.

Page 1 of 7
2 Recommended vaccinations:
Target
N Vaccine Target Group Approved Vaccine
Countries
All travelers aged 12 years
SARS-COV-2 (COVID- [Link]
1 and over, intending to All countries oved-Vaccines/Pages/[Link]
19)
perform Umrah.
Travelers arriving to perform
Umrah, particularly pregnant
women, children under 5
years, the elderly, individuals
with chronic medical
conditions (such as chronic
cardiac, pulmonary, renal,
2 Seasonal Influenza metabolic, All countries Seasonal Influenza vaccine
neurodevelopmental, liver, or
hematologic diseases) and
individuals with
immunosuppressive
conditions (such as HIV/AIDS,
receiving chemotherapy or
steroids, or malignancy).
States reporting
positive
At least one dose of (IPV)5, if (IPV) is not available, it is
environmental
3 Poliomyelitis All travelers recommended to be vaccinated with at least one dose
sites samples of
of the oral polio vaccine (OPV)6
cVDPV2 (Appendix
1-Table 3)

3 Preventive Measures by Health Authority at Points of Entry

N Disease Target Countries Approved Vaccine
Comply with local preventive regulations and procedures
SARS-COV-2
1 All countries. required by the Public Health Authority, available online on the
(COVID-19)
fallowing link ([Link]
Countries with frequent epidemics of Administer prophylactic antibiotics at the points of entry if
meningococcal meningitis, countries at risk for deemed necessary.
Meningococcal
2 meningitis epidemics, and countries with
meningitis
outbreaks of non-vaccine groups of Neisseria
meningitides (Appendix 3)
States reporting cases of WPV1 or cVDPV1 Administer one dose of bivalent oral polio vaccine (bOPV) at
3 Poliomyelitis (Appendix 1-Table 1) regardless of age and points of entry to Saudi Arabia.
vaccination status.
Yellow Fever Aircrafts, ships and other means of Valid certificate indicating that disinsection was applied in
4 Zika Virus Disease transportation arriving from countries accordance with methods recommended by WHO. They may be
and Dengue Fever affected by Yellow Fever (Appendix 2) subjected for inspection as a condition of granting free pratique.
Aircrafts, ships, and other means of
Valid certificate indicating that disinsection applied in
Zika Virus Disease transportation arriving from countries
5 accordance with methods recommended by WHO. They may be
and Dengue Fever affected with the Zika virus and/or Dengue
subjected for inspection as a condition of granting free pratique.
Fever (Appendix 4)

_________ _______ _______ ______ _______ _______ ______ _______ _______ ______ _______ ______ _______ _______ ______ _______ _______ ______ _______ _______ ______ _______ ______ _______ _______ ______ _______ _______ ______

Page 2 of 7
4 General Health Recommendations.
- Ministry of Health recommends authorities at pilgrims’ countries of origin to consider that pilgrims are free
from medical conditions that affects physical ability.
- In densely populated gatherings like during Umrah, there's a heightened risk of respiratory
infectious diseases. Therefore, it is advised to strictly adhere to wearing clean and dry masks,
frequent hand washing. With health monitoring in place for food safety in Umrah facilities, pilgrims
should ensure the safety and absence of contamination sources in their food.
- Avoid contact with those who appear ill and avoid sharing their personal belongings.
- Travelers arriving for Umrah, especially older individuals, recommended to avoid direct sun exposure while
performing rituals and to drink sufficient amount of fluids.

5 Responding to International Health Events

In the case of a public health emergency of international concern, or in the case of any event subject to
notification under the International Health Regulations (2005), the Ministry of Health will undertake all
additional necessary measures in consultation with the WHO.

_________ _______ _______ ______ _______ _______ ______ _______ _______ ______ _______ ______ _______ _______ ______ _______ _______ ______ _______ _______ ______ _______ ______ _______ _______ ______ _______ _______ ______

Page 3 of 7
7 Appendixes:

Appendix 1:
Table 1: States reporting cases of WPV1 or cVDPV1
WP1 cVDPV1
Afghanistan Madagascar
Pakistan Mozambique
DR Congo
Yemen

Table 2: States reporting cVDPV2 positive Human Sources samples or Acute Flaccid Paralysis (AFP)
cases.

cVDPV2
Nigeria Côte d'Ivoire Burundi
Tanzania Guinea Zambia
Kenya Central African Rep Burkina Faso
Chad DR Congo Benin
Yemen Mali Indonesia
South Sudan Somalia Niger
Palestine Mauritania
Zimbabwe Mozambique

Table 3: States reporting positive Environmental Sources samples of cVDPV2

cVDPV2
Egypt Cameron Sudan
Congo Angola Botswana
Malawi Algeria Senegal

Reference:
Polio Eradication Organization report on 12 February 2024.

Page 4 of 7
Appendix 2:
Countries/areas at risk of Yellow Fever transmission, as per the WHO International Travel and Health
Guidelines, are:

Americas Africa
Guyana Argentina Ghana Angola
Panama Venezuela Guinea Benin
Paraguay Bolivia Guinea-Bissau Burkina Faso
Peru Brazil Kenya Burundi
Surinam Colombia Liberia Cameroon
Ecuador Trinidad and Tobago Mali Central African Republic
French Guiana Mauritania Chad
Niger Congo
Nigeria Côte d’Ivoire
Senegal DR Congo
Sierra Leone Equatorial Guinea
Sudan Ethiopia
Gambia Gabon
Togo South Sudan
Uganda

Page 5 of 7
Appendix 3:
Countries/areas with frequent epidemics of meningococcal meningitis and countries at risk for
meningitis epidemics (WHO International Travel and Health, 2015):
Africa
Nigeria Ethiopia Benin
South Sudan Gambia Burkina Faso
Rwanda Ghana Burundi
Senegal Guinea Cameroon
Sudan Guinea-Bissau Central African Republic
Tanzania Kenya Chad
Togo Mali Côte d’Ivoire
Uganda Mauritania DR Congo
Niger Eritrea

Page 6 of 7
Appendix 4:
Countries affected with Zika and/or Dengue:
Asia Americas
Vietnam Fiji Bangladesh Dominica Anguilla
French
Papua New Guinea India Dominican Republic Antigua and Barbuda
Polynesia
Philippines Laos Indonesia Ecuador Argentina
Marshall
Samoa Maldives El Salvador Europa
Islands
Singapore Malaysia Myanmar French Guiana AL Bahama
Solomon Islands Micronesia Thailand Grenada Barbados
Tonga New Caledonia Cambodia Guadeloupe Belize
Vanuatu Palau Cook Islands Guatemala Bolivia
Sri Lanka Guyana Bonaire
Africa Haiti Sint Eustatius and Saba
Ethiopia Angola Honduras Brazil
Gabon Burkina Faso Isla de Pasqua - Chelsea British Virgin Islands
Guinea Bissau Burundi Jamaica Caiman Islands
Nigeria Cabo Verde Martinique Colombia
Senegal Cameroon Mexico Costa Rica
Central
Uganda African Montserrat Cuba
Republic
Sudan Côte d'Ivoire Nicaragua Curaçao
Saint Vincent and the
Panama
Grindins
Saint Martin Paraguay
Suriname Peru
Trinidad and Tobago Puerto Rico
Turks and Caicos Saint Barthelemy
US Virgin Islands Saint Kitts and Nevis
Venezuela Saint Lucia
Saint Martin

Page 7 of 7